|
The agency that tells the British government which treatments are worth paying for had decided last year that Sutent - at 3,500 pounds a month - was too costly to be offered at no charge under the national health care system.
The decision on the Pfizer Inc. drug, and others, led to an outcry from thousands of British cancer patients and their doctors over the denial of costly drugs that don't cure but can prolong survival, if only for 6 to 18 months.
These are the decisions we will see here if we allow the govt to take over health care.
Slàinte,
Patch
|
Brit Officials Wrestle With Cost Of Cancer Drugs
